| Literature DB >> 32483547 |
Soo-Hong Kim1, Yong-Hoon Cho1, Hae-Young Kim1.
Abstract
PURPOSE: Perforation of choledochal cyst (CC) is a relatively rare clinical presentation in pediatric populations and difficult to predict preoperatively. We assess the clinical implications by comparing clinical parameters based on a single-center experience between perforated and nonperforated CC to facilitate the appropriate management for future interventions.Entities:
Keywords: C-reactive protein; Choledochal cyst; Fever; Initial; Perforated; Visit
Year: 2020 PMID: 32483547 PMCID: PMC7231744 DOI: 10.5223/pghn.2020.23.3.259
Source DB: PubMed Journal: Pediatr Gastroenterol Hepatol Nutr ISSN: 2234-8840
Clinical features of perforated choledochal cyst
| Case | Sex/age | Main Sx&Sn | Sx duration | Perforation site | Radiologic finding |
|---|---|---|---|---|---|
| 1 | M/10 mo | Vomiting | 10 d | Ant. wall of the cyst: free perforation | Localized perihepatic fluid collection+CBD dilatation |
| 2 | F/22 mo | Abd pain, fever | 15 d | Necrotic change | GB collapse, ascites |
| 3 | F/18 mo | Rigidity, vomiting, fever | 4 d | CHD necrosis: loss of ductal structure | Massive ascites (+) |
| GB and CBD dilatation | |||||
| Type 1 | |||||
| 4 | F/32 mo | RUQ pain, vomiting, fever | 5 d | Post. wall of the CBD: free perforation | Massive ascites |
| GB collapse | |||||
| Mild dilatation of CBD | |||||
| 5 | F/20 mo | RUQ pain | 2 d | Rt. Lateral: free perforation | Massive ascites |
| GB collapse | |||||
| Type 1 | |||||
| 6 | F/18 mo | Abd pain, diarrhea, fever | 2 d | Ant. wall: pinpoint | Massive ascites |
| Type IV | |||||
| Multiple CBD stones | |||||
| 7 | F/19 mo | Rigidity, vomiting, fever | 4 hr | Rt. post. wall: pinpoint | Massive ascites |
| Type 1 | |||||
| 8 | M/6 mo | Fever | 13 d | Necrosis: loss of structure | Localized fluid collection |
| Collapsed GB |
Sx: symptom, Sn: sign, M: male, F: female, Abd: abdominal, RUQ: right upper quadrant, Ant.: anterior, CHD: common hepatic duct, Post.: posterior, CBD: common bile duct, Rt.: right, GB: gallbladder.
Demographic findings
| Variable | Perforated group (n=8) | Nonperforated group (n=84) | |||
|---|---|---|---|---|---|
| Composition | 8.7 | 91.3 | - | ||
| Sex | |||||
| Male | 2 (25.0) | 13 (15.5) | 0.612 | ||
| Female | 6 (75.0) | 71 (84.5) | |||
| Age (mo) | 19.5±8.7 (6.0–32) | 54.2±52.5 (0–192) | 0.161 | ||
| Age group | |||||
| Neonate | - | 2 (2.4) | 0.005 | ||
| Infant (−12 mo) | 2 (25.0) | 21 (25.0) | |||
| Childhood | |||||
| −24 mo | 5 (62.5) | 10 (11.9) | |||
| >24 mo | 1 (12.5) | 51 (60.7) | |||
| Perforation rate | |||||
| Neonate | 0/2 (0.0) | 0.005 | |||
| Infant (−12 mo) | 2/23 (8.7) | ||||
| Childhood | |||||
| −24 mo | 5/15 (33.3) | ||||
| >24 mo | 1/52 (1.9) | ||||
| Body weight (kg) | 10.6±1.5 (5.0–12.1) | 19.2±14.8 (2.4–52.1) | 0.307 | ||
Values are presented as number (%) or mean±standard deviation (range).
Comparison of clinical characteristics between the perforated and nonperforated groups
| Variable | Perforated group (n=8) | Nonperforated group (n=84) | ||
|---|---|---|---|---|
| Fever at initial visiting | ||||
| Yes | 6 (75.0) | 9 (10.7) | <0.001 | |
| No | 2 (25.0) | 75 (89.3) | ||
| Choledocholithiasis | ||||
| Yes | 1 (12.5) | 10 (11.9) | 0.961 | |
| No | 7 (87.5) | 74 (88.1) | ||
| WBC (103/μL) (mean 6–12)* | 11.7±6.07 (6.2–23.4) | 11.2±4.7 (5.6–25.7) | 1.000 | |
| CRP (mg/dL) (0–0.5)* | 3.4±2.6 (0.36–6.4) | 1.1±1.8 (0.01–9.2) | 0.006 | |
| AST (IU/L) (15–60)* | 109.1±95.5 (27.0–289.0) | 144.4±133.9 (18.0–626.0) | 0.533 | |
| ALT (IU/L) (13–45)* | 140.3±119.7 (8.0–296.0) | 146.4±135.6 (5.0–566.0) | 0.949 | |
| ALP (IU/L) (124–341)* | 654.8±345.3 (279.0–1,191.0) | 769.4±610.0 (186.0–3,042.0) | 0.889 | |
| GGT (IU/L) (9–64)* | 282.7±109.7 (204.0–408.0) | 460.6±396.5 (10.0–1,256.0) | 0.516 | |
| Bilirubin (mg/dL) (0.3–1.2)* | 2.3±1.4 (0.9–4.2) | 2.8±3.5 (0.25–15.1) | 0.422 | |
| Amylase (IU/L) (22–80)* | 205.5±206.3 (6.0–583.0) | 371.7±674.1 (2.5–3,492.0) | 0.924 | |
| Lipase (IU/L) (7–39)* | 438.0±340.6 (127.0–923.0) | 977.3±1,474.1 (7.0–5,944.0) | 0.927 | |
| Postoperative fasting time (d) | 3.9±1.3 (2.0–8.0) | 3.5±1.1 (2.0–6.0) | 0.876 | |
| Length of hospital stay (d) | 12.2±4.6 (8.0–22.0) | 7.8±1.2 (6.0–10.0) | 0.001 | |
Values are presented as number (%) or mean±standard deviation.
WBC: white blood cell, CRP: C-reactive protein, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, GGT: gamma-glutamyl transferase.
*Reference value.
Predictable value of perforated choledochal cyst
| Variable | Perforated group (n=8) | Nonperforated group (n=84) | Odds ratio | 95% Confidence interval | |
|---|---|---|---|---|---|
| Age group | |||||
| <24 mo | 7 | 33 | 9.8 | 1.153–83.271 | |
| >24 mo | 1 | 51 | |||
| Fever | |||||
| Yes | 6 | 9 | 25.0 | 4.374–142.9 | |
| No | 2 | 75 | |||
| Stone | |||||
| Yes | 1 | 10 | 1.057 | 0.118–9.51 | |
| No | 7 | 74 | |||